Posterior Capsular Opacification A Problem Reduced but Not Yet Eradicated

被引:312
作者
Awasthi, Niranjan [1 ,2 ]
Guo, Suqin [3 ]
Wagner, B. J. [2 ,3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Ophthalmol, Newark, NJ 07103 USA
关键词
LENS EPITHELIAL-CELLS; PEDIATRIC CATARACT-SURGERY; GROWTH-FACTOR-BETA; ND-YAG LASER; RANDOMIZED PROSPECTIVE TRIAL; SILICONE INTRAOCULAR LENSES; HUMAN AUTOPSY EYES; COLLAGEN TYPE-IV; IN-VITRO; TGF-BETA;
D O I
10.1001/archophthalmol.2009.3
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Posterior capsular opacification (PCO) is the most frequent complication of cataract surgery. Advances in surgical techniques, intraocular lens materials, and designs have reduced the PCO rate, but it is still a significant problem. The only effective treatment for PCO, Nd:YAG laser capsulotomy carries vision-related complications and risks and puts a significant financial burden on the health care system. This review contains current knowledge about the mechanisms of PCO development. Posterior capsular opacification is caused mainly by remnant lens epithelial cell proliferation and migration, epithelial-mesenchymal transition, collagen deposition, and lens fiber generation. All of these processes are influenced by cytokines, growth factors, and extracellular matrix proteins. We also describe advances and improvements in surgical techniques, intraocular lens materials, and the designs and use of therapeutic agents leading to safe, effective, and less expensive strategies to eradicate PCO.
引用
收藏
页码:555 / 562
页数:8
相关论文
共 131 条
[1]
Sealed-capsule irrigation device [J].
Agarwal, A ;
Agarwal, S ;
Agarwal, A ;
Maloof, A .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2003, 29 (12) :2274-2276
[2]
POSTERIOR CAPSULE OPACIFICATION [J].
APPLE, DJ ;
SOLOMON, KD ;
TETZ, MR ;
ASSIA, EI ;
HOLLAND, EY ;
LEGLER, UFC ;
TSAI, JC ;
CASTANEDA, VE ;
HOGGATT, JP ;
KOSTICK, AMP .
SURVEY OF OPHTHALMOLOGY, 1992, 37 (02) :73-116
[3]
Eradication of posterior capsule opacification -: Documentation. of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem [J].
Apple, DJ ;
Peng, Q ;
Visessook, N ;
Werner, L ;
Pandey, SK ;
Escobar-Gomez, M ;
Ram, J ;
Auffarth, GU .
OPHTHALMOLOGY, 2001, 108 (03) :505-518
[4]
Use of Nd:YAG laser capsulotomy [J].
Aslam, TM ;
Devlin, H ;
Dhillon, B .
SURVEY OF OPHTHALMOLOGY, 2003, 48 (06) :594-612
[5]
TREATMENT OF SECONDARY POSTERIOR CAPSULAR MEMBRANES WITH THE ND-YAG LASER IN A PEDIATRIC POPULATION [J].
ATKINSON, CS ;
HILES, DA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :496-501
[6]
Downregulation of MMP-2 and-9 by proteasome inhibition: A possible mechanism to decrease LEC migration and prevent posterior capsular opacification [J].
Awasthi, Niranjan ;
Wang-Su, Shuh Tuan ;
Wagner, B. J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (05) :1998-2003
[7]
Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification [J].
Awasthi, Niranjan ;
Wagner, B. J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (10) :4482-4489
[8]
Inhibition of lens epithelial cell adhesion by the calcium antagonist Mibefradil correlates with impaired integrin distribution and organization of the cytoskeleton [J].
Beck, R ;
Nebe, B ;
Guthoff, R ;
Rychly, J .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2001, 239 (06) :452-458
[9]
Beebe D C., 2003, Adler's physiology of the eye, P117
[10]
BEHARCOHEN FF, 1995, INVEST OPHTH VIS SCI, V36, P2434